Oncology & Cancer

Scientists identify new target for melanoma immunotherapy

QIMR Berghofer research has found a new reason why some melanoma patients do not respond well to immunotherapy—a discovery that could lead to better-tailored treatments for the potentially deadly cancer.

Oncology & Cancer

Melanoma is killing fewest Americans in decades

Advances in treatment have led to the largest yearly declines in deaths due to melanoma ever recorded for this skin cancer, results of a new study suggest.

page 6 from 16